Bromfenac Solution/ Drops
Product Images NDC 68083-313

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromfenac (NDC 68083-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bromfenac-spl-carton.jpg (Bromfenac Spl Carton)

This text appears to be a mix of misspelled words and fragmented sentences with incomplete words. Therefore, it is not possible to generate a useful description of its content.*

FDA Label Image

Bromfenac-spl-container.jpg (Bromfenac Spl Container)

NDC 68083-313-01 is an ophthalmic solution containing 1.7 mL of Bromfenac for topical application in the eye. It is intended for once-daily use and is available only by prescription. The solution should be stored at 15° to 25°C (59° to 77°F). It is manufactured by Gland Pharma Limited in SA80 Hyderabad, India and is labeled with M.L. No.: 103/AP/RR/97/FIR. Additional text is not available.*

FDA Label Image

Bromfenac-spl-structure (Bromfenac Spl Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.